Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysis

This publication has 31 references indexed in Scilit:

• Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population
  Ultrasound in Obstetrics & Gynecology, 1998
• UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation
  The Lancet, 1998
• Evaluation of first-trimester screening by fetal nuchal translucency and maternal age
  Prenatal Diagnosis, 1998
• First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucency
  Ultrasound in Obstetrics & Gynecology, 1997
• Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy
  BJOG: An International Journal of Obstetrics and Gynaecology, 1994
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
  BMJ, 1992
• Maternal serum screening for Down's syndrome in early pregnancy.
  BMJ, 1988
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities
  American Journal of Obstetrics and Gynecology, 1984
• MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROME
  The Lancet, 1984